The effect of Pecavaptan in patients with heart failure with reduced versus preserved ejection fraction - a post hoc analysis of the AVANTI trial
9 May 2026 (09:30 - 10:00)
Organised by: 
About the speaker
University Medical Centre Groningen, Groningen (Netherlands (The))
3 More presentations in this session
Doctor L. Cosic (Groningen, NL)
Doctor G. Crisci (Hasselt, BE)
Access the full session
The Event
Heart Failure 2026
9 May 2026
09:30 CET
You may be interested in
Congress Session
Congress Session
